Journal
NATURE REVIEWS ENDOCRINOLOGY
Volume 7, Issue 7, Pages 380-381Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrendo.2011.80
Keywords
-
Categories
Ask authors/readers for more resources
Advances in the development of bone-modifying agents have led to the approval of new drugs for the prevention and treatment of skeletal-related events in patients with bone metastases from breast cancer. In light of these advances, the American Society of Clinical Oncology has published a guideline update.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
